Soleno Therapeutics Total Revenue

Soleno Therapeutics (SLNO) currently reports a total revenue of $290M as of March 2026. In the prior-year period, the figure was $0. That is below the Healthcare sector average of $110B. Use the charts on this page to explore Soleno Therapeutics's total revenue history and peer comparisons.

Soleno Therapeutics's total revenue changed from $0 to $290M (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Soleno Therapeutics's total revenue of $290M is lower than the Healthcare sector average of $110B. That is roughly 99.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Soleno Therapeutics reported $290M in total revenue as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total revenue of $290M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for Soleno Therapeutics, and consider following SLNO for alerts when major investors trade the stock.